It's only been two weeks and we already miss The Extracellular Matrix Pharmacology Congress! We are looking forward to the third congress in 2026. Here's a lovely pic of Bruna M. and Mark Skarsfeldt having the time of their lives on booth duty (don't worry, they had plenty of coffee to keep them happy for visitors). Now that the vacation season is in full steam, we wish everyone a great summer, and a better weather than what we have in Denmark! 🌞
Nordic Bioscience
Forskning inden for bioteknologi
Herlev, Capital Region 16.938 følgere
Improving preclinical and clinical trial success rates with world-leading biomarkers & specialized laboratory services.
Om os
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research. We support some of the largest pharmaceutical companies in preclinical and clinical research with three decades of experience in biomarker development. With more than 650 peer-reviewed publications, our science-driven approach has been the evolving force behind our decades of success. Through our Protein Fingerprint technology, we identify fragments of the ECM that are released from affected tissues and develop blood-based biomarker assays to quantify disease activity with the aim of precision medicine. By quantifying tissue remodeling, our biomarkers provide true prognostic and predictive value, as we can select the patients who are most likely to respond to a given treatment and thereby function as surrogate biomarkers for clinical trials. Our biomarker assays not only enable faster drug development but also improve disease outcomes for chronically ill patients by predicting treatment response. Nordic Bioscience is headquartered in Herlev, Denmark, with a high-quality standard laboratory, running clinical trials under Good Clinical Laboratory Practice (GCLP) with accreditation by the College of American Pathologists (CAP) and ISO9001 certificate. Everything in our laboratory supports compliance with FDA 21 CFR Part 11. We employ more than 180 people who are dedicated to improving patient management for a broad range of therapeutic areas including Hepatology, Rheumatology, Dermatology, Oncology, Gastroenterology, Respiratory, Neurodegenerative and Cardiovascular diseases. Read more about us: https://www.nordicbioscience.com/about/about-us
- Websted
-
http://nordicbioscience.com/
Eksternt link til Nordic Bioscience
- Branche
- Forskning inden for bioteknologi
- Virksomhedsstørrelse
- 51-200 medarbejdere
- Hovedkvarter
- Herlev, Capital Region
- Type
- Privat
- Grundlagt
- 1991
- Specialer
- biomarkers, predictive biomarkers, translational biomarkers, bioassay, oncology, fibrosis, rheumatoid arthritis, rheumatology, cancer, osteoporosis, osteoarthritis, assay development, alzheimer's, clinical trials, clinical development, serological biomarkers, consultancy, scientific collaboration, neurodegenerative conditions, biotechnology, hepatology, dermatology, cardiovascular diseases, respiratory diseases, gastroenterology, prognostic biomarkers, protein fingerprint, precision medicine, drug development, clinical research, tumor fibrosis, IPF, COPD, trial enrichment og patient stratification
Beliggenheder
-
Primær
Herlev Hovedgade 205
Herlev, Capital Region 2730, DK
Medarbejdere hos Nordic Bioscience
Opdateringer
-
We are at #ECM2024 in Copenhagen - this is going to be a fantastic conference focused on the extracellular matrix and #pharmacology. We also have a booth (near the buffet area 😉) and we look forward to connecting with peers over a cup of coffee! ☕ #drugdevelopment #precisionmedicine Mayuur Bajaj Sarah Rønnow Rune Vestermark Signe Hausgaard Larsen Claus S. von Arenstorff Elijah Aighobahi Bruna M. Daniel Gabor
-
-
Tomorrow! 🤩
The Extracellular Matrix Pharmacology Congress 2024 kicks off tomorrow! The program booklet is ready for download here: https://lnkd.in/emQkxec4 This is your last chance to register: https://lnkd.in/eVbW-QWB We are super excited to welcome you to Copenhagen for 2.5 days of networking and state-of-the-art research! Thank you to the Scientific Committee, speakers, sponsors, and media partners for your support in advancing the rapidly expanding field of ECM research. #ECM2024 #congress #copenhagen #fibrosis #inflammation #drugdiscovery
-
We recently launched our much anticipated FIB-NIT™ biomarker panel to help guide drug development in fibrotic diseases! Among others, FIB-NIT™ can be used in liver, lung, heart, kidney, skin, and intestinal diseases where the common denominator is fibrotic tissue formation. Now you can visit our webpage and decide whether FIB-NIT™ would be a valuable addition to your clinical research program ➡️ https://lnkd.in/db7Ns6QA Diana Julie Leeming Morten Asser Karsdal Federica Genovese Joachim H. Mortensen Jannie M. B. Sand Signe Holm Nielsen, PhD. Rune Vestermark Sarah Rønnow Mayuur Bajaj Elijah Aighobahi Signe Hausgaard Larsen Daniel Gabor #FIBNIT #drugdevelopment #precisionmedicine #fibrosis #clinicaltrials
FIB-NIT™ panel - Nordic Bioscience
nordicbioscience.com
-
We are SO excited for #ECM2024! Amazing program, amazing science, amazing location, and amazing weather(?)—the countdown has begun!
1 week left until The Extracellular Matrix Pharmacology Congress 2024 kicks off! The program booklet is ready for download here and on the congress website: https://lnkd.in/emQkxec4 Haven't registered yet? Last chance! https://lnkd.in/eVbW-QWB We are looking forward to welcoming you in Copenhagen on 17-19 June for an unforgettable mix of networking and state-of-the-art research. Check out our social events here: https://lnkd.in/euHFtWud Thank you to the Scientific Committee, speakers, sponsors, and media partners for your support in advancing the rapidly expanding field of ECM research! #ECM2024 #congress #copenhagen #fibrosis #inflammation #drugdiscovery
-
Wrapping up an incredible week at #EASL2024 in Milan! We are extremely proud of our FIB-NIT™ panel being showcased and utilized by many of our esteemed collaborators. The presentations and discussions around fibroblast activity and its prognostic power have been truly inspiring. Special recognition to Diana Julie Leeming and her team for their outstanding work that has brought us to this pivotal moment. Seeing the final version of PRO-C3 on the ROCHE-COBAS 801 flagship analyzer, ready to make a difference in patients' lives, is a testament to the hard work and dedication of our teams. This week has reinforced the potential of weight-dependent and weight-independent interventions to de-activate fibroblasts, offering new hope for patients with liver fibrosis. Morten Asser Karsdal Rune Vestermark Diana Julie Leeming Alejandro Mayorca Guiliani Thomas Wiggers Emilie Skovgaard
-
-
Nordic Bioscience genopslog dette
We need to change fibroblast activities - we need ECM pharmacology !
The Extracellular Matrix Pharmacology Congress is here in less than 2 weeks! We can’t wait to see you in person in Copenhagen on June 17-19. Not registered yet? Last chance! https://lnkd.in/eVbW-QWB We have an exciting program lined up: https://lnkd.in/emQkxec4 What to expect? Presentations from keynote speakers within the ECM field and industry experts and researchers focusing on elastin and collagens in health, aging and disease; the fibro-inflammatory axis; unraveling ECM dynamics; drug development in fibrosis; targeting and quantifying fibrosis and inflammation using digital pathology, AI, biomarkers, and appropriate model systems, and the role of proteomics in advancing precision medicine. At #ECM2024, we aim to offer an unforgettable mix of networking and state-of-the-art research. Remember to check out our social events here: https://lnkd.in/euHFtWud
Registration
https://ecm-congress.org
-
We are going to the #EASLCongress! You can find us at booth BT5 in the Biotech Village where you can also meet the team. We have also produced new research with our collaborators —see our presentation guide below. Fancy a meetup? Reach out to Rune Vestermark to connect! Diana Julie Leeming Morten Asser Karsdal Alejandro Mayorca Guiliani Emilie Skovgaard Thomas Wiggers #EASL2024 #liver #fibrosis #precisionmedicine #drugdevelopment
-
Nordic Bioscience genopslog dette
The Extracellular Matrix Pharmacology Congress is here in less than 2 weeks! We can’t wait to see you in person in Copenhagen on June 17-19. Not registered yet? Last chance! https://lnkd.in/eVbW-QWB We have an exciting program lined up: https://lnkd.in/emQkxec4 What to expect? Presentations from keynote speakers within the ECM field and industry experts and researchers focusing on elastin and collagens in health, aging and disease; the fibro-inflammatory axis; unraveling ECM dynamics; drug development in fibrosis; targeting and quantifying fibrosis and inflammation using digital pathology, AI, biomarkers, and appropriate model systems, and the role of proteomics in advancing precision medicine. At #ECM2024, we aim to offer an unforgettable mix of networking and state-of-the-art research. Remember to check out our social events here: https://lnkd.in/euHFtWud
Registration
https://ecm-congress.org
Tilsvarende sider
Finansiering
Seneste runde
Privat egenkapital100.000.000,00 US$
Investorer